1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Cancer Drug News 27 APRIL 2015

Cancer Drug News 27 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Celgene's Haematology Expertise Will Benefit AstraZeneca
Industry Brief - Halaven Launched In UAE For MBC
Industry Brief - Arzerra Phase III Study Meets Primary Endpoint Of PFS In Relapsed CLL
Industry Brief - MedImmune/Juno Enter Immuno-Oncology Trial Collaboration
Industry Trend Analysis - Pfizer Cannot Rely Solely On Resurrecting Shelved Oncology Candidates To Drive Growth
Industry Brief - Onconova Submits Rigosertib Trial Protocol To FDA/EMA In Higher-Risk MDS
Industry Brief - FDA Accepts Adcetris sBLA; Grants Priority Review For HL Following ASCT
Industry Brief - Pomalyst Meets Accelerated Approval Requirements For r/r MM
Industry Brief - Ono Seeks Japanese Approval For Additional Indication Of Opdivo
Industry Brief - Xalkori Gains FDA Breakthrough Therapy Designation For ROS1-Positive NSCLC
Industry Trend Analysis - AstraZeneca Will Continue To Increase Oncology Segment's Strength
Industry Brief - ARIAD Granted US Patent Covering Brigatinib
Industry Trend Analysis - Genomic Profiling Expanding Utility Of Targeted Drugs
Industry Brief - Nymox' NX-1207 Phase II Trial Improves Outcomes In PCA
Industry Brief - Dosing Begins In Demcizumab Phase II Trial For First-Line MPC
Industry Brief - Oasmia's Paclical Approved In Russia
Industry Brief - CanTx' Cantrixil Gains FDA ODD For OC
Industry Brief - Lilly's Cyramza Gains Fourth FDA Approval
Industry Brief - FDA Grants ODD To SolaranRx' SRX-1177 For Late-Stage Malignant Melanoma
Industry Brief - CHMP Adopts Positive Opinion On Opdivo For Advanced Melanoma
Industry Trend Analysis - Immuno-Oncology Market Will Become Crowded As Focus Increases
Industry Brief - Batu Granted US Patent Covering ImmXcyte
Industry Brief - Curadev/Roche Enter Cancer Immunotherapy Deal
Industry Trend Analysis - GSK Oncology Additions To Increase Novartis' Growth Trajectory
Industry Brief - AbbVie Extends Exchange Offer To Acquire Pharmacyclics

Table Of Contents

Cancer Drug News 27 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global tumor ablation market is estimated to register a high CAGR of 12.5% during 2016-2021, and is expected to be valued at ~USD 580.1 million in 2021. Although mature markets (North America and Europe) ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.